Adsorbocarpine Ophthalmic Drops, Solution 2pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Adsorbocarpine: Ophthalmic drops, solution (2%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PILOCARPINE (PYE loe KAR peen) is used in the eye to decrease pressure in certain kinds of glaucoma. It is also used to prepare the eyes for surgery.

In-Depth Information

Adsorbocarpine 2% Ophthalmic Solution

NDC: 009980213
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Glaucoma, Increased Intraocular Pressure, Miosis Induction, Ocular Hypertension

Adsorbocarpine 2% Ophthalmic Solution

Reported Side Effects for Adsorbocarpine 2% Ophthalmic Solution

Headache Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Eye Pain Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
>5.0%*
Severity: MILD
Onset: RAPID
Visual Impairment Incidence:
>5.0%*
Severity: SEVERE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Adsorbocarpine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5